PAPA Medical Inc.
PAPA
NASDAQ
Recommendation
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | 51.72% | 40.94% | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 51.72% | 40.94% | -- | -- | -- |
Cost of Revenue | 56.80% | 43.93% | -- | -- | -- |
Gross Profit | 37.40% | 32.54% | -- | -- | -- |
SG&A Expenses | 72.38% | 87.05% | -- | -- | -- |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 60.19% | 51.97% | -- | -- | -- |
Operating Income | -45.84% | -64.92% | -- | -- | -- |
Income Before Tax | -49.13% | -69.52% | -- | -- | -- |
Income Tax Expenses | -82.10% | -86.56% | -- | -- | -- |
Earnings from Continuing Operations | -33.17% | -62.09% | -- | -- | -- |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -33.17% | -62.09% | -- | -- | -- |
EBIT | -45.84% | -64.92% | -- | -- | -- |
EBITDA | -23.94% | -45.89% | -- | -- | -- |
EPS Basic | -33.10% | -62.10% | -- | -- | -- |
Normalized Basic EPS | -44.97% | -66.09% | -- | -- | -- |
EPS Diluted | -33.10% | -62.10% | -- | -- | -- |
Normalized Diluted EPS | -44.97% | -66.09% | -- | -- | -- |
Average Basic Shares Outstanding | 0.00% | 0.00% | -- | -- | -- |
Average Diluted Shares Outstanding | 0.00% | 0.00% | -- | -- | -- |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |